Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease

Younossi, Zobair M. and Alqahtani, Saleh A. and Alswat, Khalid and Yilmaz, Yusuf and Keklikkiran, Caglayan and Funuyet-Salas, Jesus and Romero-Gomez, Manuel and Fan, Jian-Gao and Zheng, Ming-Hua and El-Kassas, Mohamed and Castera, Laurent and Liu, Chun-Jen and Wong, Vincent Wai-Sun and Zelber-Sagi, Shira and Allen, Alina M. and Lam, Brian and Treeprasertsuk, Sombat and Hameed, Saeed and Takahashi, Hirokazu and Kawaguchi, Takumi and Schattenberg, Joern M. and Duseja, Ajay and Newsome, Phil N. and Francque, Sven and Spearman, C. Wendy and Fernandez, Marlen I. Castellanos and Burra, Patrizia and Roberts, Stuart K. and Chan, Wah-Kheong and Arrese, Marco and Silva, Marcelo and Rinella, Mary and Singal, Ashwani K. and Gordon, Stuart and Fuchs, Michael and Alkhouri, Naim and Cusi, Kenneth and Loomba, Rohit and Ranagan, Jane and Eskridge, Wayne and Kautz, Achim and Ong, Janus P. and Kugelmas, Marcelo and Eguchi, Yuichiro and Diago, Moises and Yu, Ming-Lung and Gerber, Lynn and Fornaresio, Lisa and Nader, Fatema and Henry, Linda and Racila, Andrei and Golabi, Pegah and Stepanova, Maria and Carrieri, Patrizia and Lazarus, Jeffrey and Council, Global Nash (2024) Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease. Journal of Hepatology, 80 (3). ISSN 0168-8278, DOI https://doi.org/10.1016/j.jhep.2023.11.004.

Full text not available from this repository.
Official URL: https://doi.org/10.1016/j.jhep.2023.11.004

Abstract

Background & Aims: Patients with fatty liver disease may experience stigma from the disease or comorbidities. In this cross-sectional study, we aimed to understand stigma among patients with nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) and healthcare providers. Methods: Members of the Global NASH Council created two surveys about experiences/attitudes toward NAFLD and related diagnostic terms: a 68-item patient and a 41-item provider survey. Results: Surveys were completed by 1,976 patients with NAFLD across 23 countries (51% Middle East/North Africa MENA], 19% Europe, 17% USA, 8% Southeast Asia, 5% South Asia) and 825 healthcare providers (67% gastroenterologists/hepatologists) across 25 countries (39% MENA, 28% Southeast Asia, 22% USA, 6% South Asia, 3% Europe). Of all patients, 48% ever disclosed having NAFLD/NASH to family/friends; the most commonly used term was ``fatty liver'' (88% at least sometimes); ``metabolic disease'' or ``MAFLD'' were rarely used (never by >84%). Regarding various perceptions of diagnostic terms by patients, there were no substantial differences between ``NAFLD'', ``fatty liver disease (FLD)'', ``NASH'', or ``MAFLD''. The most popular response was being neither comfortable nor uncomfortable with either term (56%-71%), with slightly greater discomfort with ``FLD'' among the US and South Asian patients (47-52% uncomfortable). Although 26% of patients reported stigma related to overweight/obesity, only 8% reported a history of stigmatization or discrimination due to NAFLD. Among providers, 38% believed that the term ``fatty'' was stigmatizing, while 34% believed that ``nonalcoholic'' was stigmatizing, more commonly in MENA (43%); 42% providers (gastroenterologists/hepatologists 45% vs. 37% other specialties, p = 0.03) believed that the name change to metabolic dysfunction-associated steatotic liver disease (or MASLD) might reduce stigma. Regarding the new nomenclature, the percentage of providers reporting ``steatotic liver disease'' as stigmatizing was low (14%). Conclusions: The perception of NAFLD stigma varies among patients, providers, geographic locations and sub-specialties. (c) 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Item Type: Article
Funders: Center for Outcomes Research in Liver Diseases (COR-LD)
Uncontrolled Keywords: fatty liver; discrimination; patient-reported outcomes; communication; metabolic; MASLD; MASH; SLD
Subjects: R Medicine > R Medicine (General)
Divisions: Universiti Malaya Medical Centre (UMMC)
Depositing User: Ms. Juhaida Abd Rahim
Date Deposited: 06 Nov 2024 06:40
Last Modified: 06 Nov 2024 06:40
URI: http://eprints.um.edu.my/id/eprint/45622

Actions (login required)

View Item View Item